Farmhispania Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.
One of their notable products is EVEROLIMUS (2.0% BHT), with a corresponding US DMF Number 34295.
Remarkably, this DMF maintains an Active status since its submission on December 20, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 28, 2020, and payment made on December 23, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II